Provided by Tiger Trade Technology Pte. Ltd.

Jupiter Neurosciences

2.77
-0.0700-2.46%
Post-market: 2.770.00000.00%19:30 EDT
Volume:36.89K
Turnover:101.35K
Market Cap:3.65M
PE:-0.15
High:2.85
Open:2.70
Low:2.66
Close:2.84
52wk High:135.75
52wk Low:2.25
Shares:1.32M
Float Shares:1.10M
Volume Ratio:0.18
T/O Rate:3.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.5676
EPS(LYR):-18.7500
ROE:-1888.70%
ROA:-159.56%
PB:-9.98
PE(LYR):-0.15

Loading ...

Pharmala Biotech - to Receive 3% Royalty on U.S. Net Sales After Third Milestone

THOMSON REUTERS
·
Jul 21

Jupiter Neurosciences Names Former White House Economic Adviser Tomas Philipson to Board

Reuters
·
Jul 07

Jupiter Neurosciences Strengthens Board with Appointment of DR. Tomas J. Philipson

THOMSON REUTERS
·
Jul 07

Jupiter Neurosciences Appoints Tomas J. Philipson to Board

Reuters
·
Jul 01

Top Premarket Decliners

MT Newswires Live
·
Jun 29

Jupiter Neurosciences - Files for Resale of up to 16 Mln Shares by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
Jun 27

Jupiter Neurosciences Announces Board Member Resignation and Vacancy

TIPRANKS
·
Jun 22

Jupiter Neurosciences director Allison Brady resigns from board, committees

Reuters
·
Jun 22

Sk Pharmteco Announces Strategic Collaboration With Orphan Therapeutics Accelerator

Reuters
·
Jun 18

Jupiter Neurosciences Promotes Silva to COO and President

TIPRANKS
·
Jun 06

Jupiter Neurosciences commences patient enrollment in RESET trial

TIPRANKS
·
May 27

Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a Reset Trial in Parkinson’s Disease

THOMSON REUTERS
·
May 27

Jupiter Neurosciences closes $2 million registered direct offering

Reuters
·
May 22

Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering

THOMSON REUTERS
·
May 22

Jupiter Neurosciences Inc - Files for Offering of 7.14 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
May 21

Jupiter Neurosciences prices registered direct offering at USD 2 million

Reuters
·
May 21

Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering

THOMSON REUTERS
·
May 21

Jupiter Neurosciences Inc - to Buy Exclusive U.S. Rights to Ala-002 From Pharmala Biotech

THOMSON REUTERS
·
May 20

Jupiter Neurosciences agrees to pay $3.33 million for exclusive US rights to PharmAla’s ALA-002

Reuters
·
May 20

Jupiter Neurosciences Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $18.652K Miss $225.000K Estimate

Benzinga Earnings
·
May 15